Literature DB >> 8919964

Alterations in the equine herpesvirus type-1 (EHV-1) strain RacH during attenuation.

P H Hübert1, S Birkenmaier, H J Rziha, N Osterrieder.   

Abstract

The equine herpesvirus type-1 modified live-vaccine strain RacH (256th passage on porcine embryonic kidney cells) was investigated by restriction-enzyme analysis and compared to representative plaque isolates of the 12th passage (RacL11, RacL22) and 185th passage (RacM24, RacM36). The restriction patterns of all Rac plaque isolates differed compared with reference strain Ab4. The left UL terminus was shortened by 0.1 kbp and a missing BamHI site led to the fusion of the f and t fragments. In some Rac derivatives, losses of restriction sites without deletions were observed: 1. One BamHI site located in the ribosyl reductase gene was missing in RacH, RacM24, RacM36, and RacL22; and 2. An SalI site mapping to the gp14 (gB) gene was absent in RacM24, RacM36 and RacH. An identical deletion of 0.85 kbp in size was found in both copies of the inverted repeat (IR) regions of RacH. The deletion was present only in the terminal IR of the medium-passage derivative RacM36. By contrast, in the genomes of the apathogenic RacM24, as well as the pathogenic plaque isolates RacL11 and RacL22, no deletions in the IRs were detectable. Nucleotide-sequence and Northern-blot analyses revealed that the deletions led to the elimination of one or both copies of the gene 67 (IR6) open-reading frame in RacM36 and RacH and affected the gene 68 (EUS1) in RacH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8919964     DOI: 10.1111/j.1439-0450.1996.tb00282.x

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN: 0514-7166


  17 in total

1.  Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I.

Authors:  Guanggang Ma; Silke Feineis; Nikolaus Osterrieder; Gerlinde R Van de Walle
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.

Authors:  Christiane L Schnabel; Susanna Babasyan; Alicia Rollins; Heather Freer; Christine L Wimer; Gillian A Perkins; Fahad Raza; Nikolaus Osterrieder; Bettina Wagner
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

3.  Localization of ERK/MAP kinase is regulated by the alphaherpesvirus tegument protein Us2.

Authors:  Mathew G Lyman; Jessica A Randall; Christine M Calton; Bruce W Banfield
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Immunological correlates of vaccination and infection for equine herpesvirus 1.

Authors:  Laura B Goodman; Christine Wimer; Edward J Dubovi; Carvel Gold; Bettina Wagner
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

5.  Potential of equine herpesvirus 1 as a vector for immunization.

Authors:  Sascha Trapp; Jens von Einem; Helga Hofmann; Josef Köstler; Jens Wild; Ralf Wagner; Martin Beer; Nikolaus Osterrieder
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  The equine herpesvirus 1 UL20 product interacts with glycoprotein K and promotes egress of mature particles.

Authors:  Simone Guggemoos; Frank T Just; Antonie Neubauer
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  The equine herpesvirus 1 Us2 homolog encodes a nonessential membrane-associated virion component.

Authors:  A Meindl; N Osterrieder
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Pseudorabies virus tegument protein Us2 recruits the mitogen-activated protein kinase extracellular-regulated kinase (ERK) to membranes through interaction with the ERK common docking domain.

Authors:  Ming-Hsi Kang; Bruce W Banfield
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

9.  Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza.

Authors:  Cristina Rosas; Gerlinde R Van de Walle; Stephan M Metzger; Karin Hoelzer; Edward J Dubovi; Sung G Kim; Colin R Parrish; Nikolaus Osterrieder
Journal:  Vaccine       Date:  2008-03-31       Impact factor: 3.641

10.  The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.

Authors:  Jens von Einem; Janet Wellington; J Millar Whalley; Kerstin Osterrieder; Dennis J O'Callaghan; Nikolaus Osterrieder
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.